Literature DB >> 21532369

Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome.

Anthony Clemons, Magdalini Vasiadi, Duraisamy Kempuraj, Taxiarchis Kourelis, Gregory Vandoros, Theoharis C Theoharides.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21532369      PMCID： PMC3498825          DOI： 10.1097/JCP.0b013e3182196e50

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  20 in total

1.  Histidine decarboxylase and histamine in discrete nuclei of rat hypothalamus and the evidence for mast-cells in the median eminence.

Authors:  H Pollard; S Bischoff; C Llorens-Cortes; J C Schwartz
Journal:  Brain Res       Date:  1976-12-24       Impact factor: 3.252

2.  Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo.

Authors:  J J Rozniecki; V Dimitriadou; M Lambracht-Hall; X Pang; T C Theoharides
Journal:  Brain Res       Date:  1999-12-04       Impact factor: 3.252

3.  Inhibition of histamine release and ionophore-induced calcium flux in rat mast cells by lidocaine and chlorpromazine.

Authors:  H G Johnson; M D Miller
Journal:  Agents Actions       Date:  1979-08

4.  Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress.

Authors:  Pamela Esposito; Nathan Chandler; Kristiana Kandere; Subimal Basu; Stanley Jacobson; Raymond Connolly; David Tutor; Theoharis C Theoharides
Journal:  J Pharmacol Exp Ther       Date:  2002-12       Impact factor: 4.030

5.  Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome.

Authors:  Andrea T White; Alan R Light; Ronald W Hughen; Lucinda Bateman; Thomas B Martins; Harry R Hill; Kathleen C Light
Journal:  Psychophysiology       Date:  2010-03-04       Impact factor: 4.016

Review 6.  Mast cells as targets of corticotropin-releasing factor and related peptides.

Authors:  Theoharis C Theoharides; Jill M Donelan; Nikoletta Papadopoulou; Jing Cao; Duraisamy Kempuraj; Pio Conti
Journal:  Trends Pharmacol Sci       Date:  2004-11       Impact factor: 14.819

Review 7.  Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions.

Authors:  Leslie A Aaron; Dedra Buchwald
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-08       Impact factor: 4.098

Review 8.  Critical role of mast cells in inflammatory diseases and the effect of acute stress.

Authors:  Theoharis C Theoharides; David E Cochrane
Journal:  J Neuroimmunol       Date:  2004-01       Impact factor: 3.478

9.  Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI.

Authors:  Arnold S Kirshenbaum; Cem Akin; Yalin Wu; Menachem Rottem; Julie P Goff; Michael A Beaven; V Koneti Rao; Dean D Metcalfe
Journal:  Leuk Res       Date:  2003-08       Impact factor: 3.156

10.  IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin.

Authors:  Theoharis C Theoharides; Bodi Zhang; Duraisamy Kempuraj; Michael Tagen; Magdalini Vasiadi; Asimenia Angelidou; Konstantinos-Dionysios Alysandratos; Dimitris Kalogeromitros; Shahrzad Asadi; Nikolaos Stavrianeas; Erika Peterson; Susan Leeman; Pio Conti
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-16       Impact factor: 11.205
View more
  7 in total

Review 1.  Recent advances in our understanding of mast cell activation - or should it be mast cell mediator disorders?

Authors:  Theoharis C Theoharides; Irene Tsilioni; Huali Ren
Journal:  Expert Rev Clin Immunol       Date:  2019-04-22       Impact factor: 4.473

2.  Amitriptyline Downregulates Chronic Inflammatory Response to Biomaterial in Mice.

Authors:  Karina Scheuermann; Laura Alejandra Ariza Orellano; Celso Tarso Rodrigues Viana; Clara Tolentino Machado; Marcela Guimarães Takahashi Lazari; Luciano Santos Aggum Capettini; Silvia Passos Andrade; Paula Peixoto Campos
Journal:  Inflammation       Date:  2020-10-09       Impact factor: 4.092

Review 3.  Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation.

Authors:  Ann C Raddant; Andrew F Russo
Journal:  Expert Rev Mol Med       Date:  2011-11-29       Impact factor: 5.600

Review 4.  Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.

Authors:  Jesus Castro-Marrero; Naia Sáez-Francàs; Dafna Santillo; Jose Alegre
Journal:  Br J Pharmacol       Date:  2017-02-01       Impact factor: 8.739

Review 5.  Fibromyalgia syndrome in need of effective treatments.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Lauren Arbetman; Smaro Panagiotidou; Julia M Stewart; Rae M Gleason; Irwin J Russell
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

6.  Amitriptyline protects against TNF-α-induced atrophy and reduction in synaptic markers via a Trk-dependent mechanism.

Authors:  Eimear O'Neill; Billy Kwok; Jennifer S Day; Thomas J Connor; Andrew Harkin
Journal:  Pharmacol Res Perspect       Date:  2016-03-08

Review 7.  Pharmacological treatment options for mast cell activation disease.

Authors:  Gerhard J Molderings; Britta Haenisch; Stefan Brettner; Jürgen Homann; Markus Menzen; Franz Ludwig Dumoulin; Jens Panse; Joseph Butterfield; Lawrence B Afrin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-30       Impact factor: 3.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.